Heiner Dreismann

Heiner is a seasoned executive with more than 35 years of experience in the life sciences and health care industries and is regarded as a pioneer in the early adoption of polymerase chain reaction (PCR) technique, one of the most ubiquitous technologies in molecular biology and genetics research today. He earned a Master of Science degree in biology and his Ph.D. in microbiology/molecular biology (summa cum laude) from Westfaelische Wilhelms University in Muenster, Germany. He made significant contributions to the organizational and financial growth of Roche, including roles such as head of the PCR Business Unit for Europe and President and CEO of Roche Molecular Systems.